Skip to main content

The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults

Buy Article:

$36.50 + tax (Refund Policy)

Background:

This study evaluates the lymphocyte-eosinophil to neutrophil-monocyte ratio (LENMR) as a novel inflammatory indicator of the exacerbation risk in adults with asthma.

Methods:

This cross-sectional study included 1344 adults with asthma from the 2007‐2012 cycles of the National Health and Nutrition Examination Survey. The association between LENMR and asthma exacerbations was evaluated by using multivariable logistic regression with progressive adjustment for confounders. Subgroup analyses were conducted to assess the consistency of associations. Restricted cubic spline and threshold effect models were used to explore potential nonlinear relationships.

Results:

A higher LENMR was significantly associated with an increased risk of asthma exacerbations. In the fully adjusted model, the participants in the highest quartile had a 77% higher odds of exacerbation compared with the lowest quartile (odds ratio 1.77 [95% confidence interval, 1.19‐2.65]; p = 0.007). Associations were consistent across subgroups. Restricted cubic spline analysis revealed a significant nonlinear relationship, with a threshold effect identified at LENMR = 0.31.

Conclusion:

An elevated LENMR is positively associated with asthma exacerbations under specific thresholds.

Keywords: LENMR; asthma exacerbation; composite inflammatory index; inflammatory biomarkers; non-linear association; risk prediction; systemic inflammation

Document Type: Research Article

Affiliations: From the Department of Pulmonary Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China and

Publication date: September 1, 2025

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Commercial level: Permission to use content
  • www.JFoodAllergy.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content